91AV

Introduction

The program is expected to attract 400 international participants and will provide a fantastic forum for researchers in the field to network and discuss new ways to solve the global challenge of drug-resistant infections. Our goal for SDRI 2017 is to lead a concerted discussion to set three priorities and guide research efforts towards global solutions for drug resistance research.

Conference themes:

• Antimicrobial drug discovery
• Improvements to existing anti-infective agents and repurposing
• New Drug Targets
• Alternate therapies
• Vector control and vaccines
• International Models and Funding
• Successes and failures in the pipeline 

Deadlines

• Oct 14 2016
  Oral abstracts deadline

  
• Oct 14 2016
  Poster abstract deadline

  
• Dec 09 2016
  Early bird registration deadline

  

Useful links

Downloads

• SDRI 2017 conference flyer

Speakers

• Professor Dame Sally Davies DBE, FMedSci, FRS Chief Medical Officer for England, United Kingdom
• Professor Ramanan Laxminarayan PHFI and CDDEP, United States
• Dr Manica Balasegaram Director, Global Antibiotic R&D Partnership, DNDi, Switzerland
• Professor Bob Hancock University of British Columbia, Canada
• Dr Timothy Jinks Strategy Development Lead, Wellcome Trust, United Kingdom
• Dr Jennifer Leeds Novartis Institutes for BioMedical Research, Switzerland
• Dr Line Matthiessen Health European Commission , Switzerland
• Dr Terry Roemer Head of Antimicrobial Discovery, Merck, United States
• Dr David Shlaes Anti-infective Consultant, United States
• Dr Man-Wah Tan Genentech, United States
• Professor Elizabeth Winzeler University of California, United States
• Professor Gerry Wright Michael G.DeGroote Institute for Infectious Disease Research, Canada
• Dr Zuoyu Xu National Institute of Allergy and Infectious Diseases, United States

---

Sponsorship & supporting organisations

The University of Queensland Institute for Molecular Bioscience Centre for Superbug Solutions (IMB CSS)

---

Sponsors

Venue

Brisbane Convention and Exhibition Centre

Brisbane Convention and Exhibition Centre, Merivale St & Glenelg Street, South Brisbane , Brisbane, Queensland, 4101, Australia

Useful links

Committee

• Professor Vicky Avery Eskitis Institute, Griffith University, Australia
• Dr Mark Blaskovich The University of Queensland, Australia
• Professor Matthew Cooper The University of Queensland, Australia
• Professor Elizabeth Harry University of Technology Sydney, Australia
• Professor Jian Li Monash University, Australia
• Professor Paul Young The University of Queensland, Australia

---

Organised by

CO-ADD is a global open access not-for-profit initiative led by academics at The University of Queensland. Our goal is to screen compounds for antimicrobial activity for academic research groups all over the world for free. We aim to help researchers worldwide to find new, diverse compounds to combat drug-resistant infections.​

Contact information

Ruth Neale
Community for Open Antimicrobial Drug Discovery (CO-ADD)
+61 7 3346 2389
Contact us by email

---